Stéphane Laurent: Key Highlights of ISBT 2026 for INLOG
Stéphane Laurent, International Sales Director at INLOG, Consultant -Advisor at ADEN Developpement-Consulting Healthcare, shared a post on LinkedIn:
“Key Highlights of International Society of Blood Transfusion (ISBT) 2026 Kuala Lumpur for INLOG
Strengthening INLOG’s international position as a leading provider of Blood Donor Management and Blood Establishment Information Systems (BBIS).
Showcasing the complete EdgeBlood, Blood Donor Online (BDO) and EdgeCell portfolio to the global transfusion medicine community.
Meeting national Blood Services, Ministries of Health, Red Cross organizations and major hospitals from across the world.
Accelerating expansion across ASEAN, with a particular focus on Malaysia, Indonesia, Thailand, Vietnam, Singapore and the Philippines.
Developing strategic distribution partnerships with leading regional healthcare technology companies.
Exploring long-term collaborations with IVD, automation and medical device manufacturers to deliver integrated solutions.
Promoting INLOG’s 20-year experience alongside the French Blood Establishment (EFS) as a benchmark for digital transformation in transfusion medicine.
Demonstrating end-to-end digital management covering donor recruitment, collection, testing, processing, inventory, distribution, traceability and haemovigilance.
Highlighting INLOG’s expertise beyond blood management with cells, tissues, organs, cord blood and human milk bank management through EdgeCell.
Presenting innovative digital donor engagement solutions, including online donor questionnaires, appointment scheduling and donor communication.
Discussing interoperability, cybersecurity, cloud architectures, AI opportunities and international standards with healthcare partners.
International Society of Blood Transfusion (ISBT) is not only where the transfusion community meets—it is where the future of Blood Donor
Management is designed together.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic
-
Sep 25, 2026, 05:07Nancy Braithwaite: BBTS Specialist Certificate in Transfusion Science Practice
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award